Riposte Capital LLC Buys Shares of 60,000 Astera Labs, Inc. $ALAB

Riposte Capital LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 60,000 shares of the company’s stock, valued at approximately $6,576,000. Astera Labs makes up about 1.7% of Riposte Capital LLC’s portfolio, making the stock its 16th largest position.

Several other hedge funds have also recently added to or reduced their stakes in ALAB. Reflection Asset Management acquired a new position in shares of Astera Labs during the 4th quarter worth approximately $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in Astera Labs during the 4th quarter worth about $33,000. Whipplewood Advisors LLC raised its stake in Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the last quarter. Finally, Assetmark Inc. lifted its holdings in Astera Labs by 78.9% in the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Evercore reissued an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Rothschild & Co Redburn started coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. JPMorgan Chase & Co. increased their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, UBS Group raised their price target on Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research note on Monday, June 29th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $282.00.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the sale, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. The trade was a 3.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $260.23 on Wednesday. The stock has a 50-day simple moving average of $360.60 and a 200-day simple moving average of $227.59. The stock has a market capitalization of $44.61 billion, a P/E ratio of 175.83, a PEG ratio of 3.27 and a beta of 3.66. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the firm posted $0.33 earnings per share. Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts predict that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.